Overview of changes and biomarker potential of complement proteins in the cerebrospinal fluid (CSF) of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) patients compared to a control group. The gene discussed is VTN; the disease is Cognitive impairment.